210 related articles for article (PubMed ID: 32602119)
21. Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?
Berman RS; Gershenwald JE
Ann Surg Oncol; 2019 Apr; 26(4):921-923. PubMed ID: 30737667
[No Abstract] [Full Text] [Related]
22. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
23. Primary Dermal Melanoma (PDM): Histological and Clinical Interdependence to Guide Therapy.
Zamir H; Feinmesser M; Gutman H
J Cutan Med Surg; 2021; 25(1):53-58. PubMed ID: 32912013
[TBL] [Abstract][Full Text] [Related]
24. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
25. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
26. In transit sentinel node drainage as a prognostic factor for patients with cutaneous melanoma.
Brandão PHDM; Bertolli E; Doria-Filho E; Santos Filho IDAO; de Macedo MP; Pinto CAL; Duprat Neto JP
J Surg Oncol; 2018 Apr; 117(5):864-867. PubMed ID: 29484669
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
28. Current management of patients with melanoma who are found to be sentinel node-positive.
Nijhuis AAG; Spillane AJ; Stretch JR; Saw RPM; Menzies AM; Uren RF; Thompson JF; Nieweg OE
ANZ J Surg; 2020 Apr; 90(4):491-496. PubMed ID: 31667924
[TBL] [Abstract][Full Text] [Related]
29. A commentary on "Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study" - correspondence.
Saravanan M; Arockiaraj J; Belete MA
Int J Surg; 2024 Mar; 110(3):1862-1863. PubMed ID: 38116653
[No Abstract] [Full Text] [Related]
30. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
31. Clinical Prognostic Markers in Stage IIIB Melanoma.
Madu MF; Wouters MW; Klop WM; van der Hiel B; van de Wiel BA; Jóźwiak K; van der Hage JA; van Akkooi AC
Ann Surg Oncol; 2016 Dec; 23(13):4195-4202. PubMed ID: 27380642
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.
Smith OJ; Coelho JA; Trevatt AE; Ross GL
Eur J Surg Oncol; 2016 Sep; 42(9):1427-31. PubMed ID: 27262872
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
[TBL] [Abstract][Full Text] [Related]
34. Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients.
Ogata D; Tanese K; Nakamura Y; Otsuka M; Namikawa K; Funakoshi T; Yoshikawa S; Tsutsui K; Nakama K; Jinnai S; Kiyohara Y; Takahashi A; Yamazaki N
Int J Clin Oncol; 2021 Dec; 26(12):2338-2346. PubMed ID: 34545533
[TBL] [Abstract][Full Text] [Related]
35. The sentinel node biopsy has come of age.
McGregor JM
Br J Dermatol; 2019 Aug; 181(2):423. PubMed ID: 30724352
[No Abstract] [Full Text] [Related]
36. Complication rates of completion lymphadenectomy following positive sentinel lymph node biopsy versus therapeutic lymphadenectomy in melanoma.
Smith JR; Wilson A; Stone C
J Plast Reconstr Aesthet Surg; 2016 Jul; 69(7):1011-2. PubMed ID: 27184594
[No Abstract] [Full Text] [Related]
37. Sentinel Lymph Node Biopsy: Indications and Technique.
Crystal J; Faries MB
Surg Oncol Clin N Am; 2020 Jul; 29(3):401-414. PubMed ID: 32482316
[TBL] [Abstract][Full Text] [Related]
38. Melanocytic nevi in sentinel lymph nodes: association with cutaneous nevi and clinical relevance in patients with cutaneous melanomas.
Kretschmer L; Schnabel V; Kromer C; Bauer-Büntzel C; Richter A; Bremmer F; Kück F; Julius K; Mitteldorf C; Schön MP
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3125-3134. PubMed ID: 35059868
[TBL] [Abstract][Full Text] [Related]
39. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
40. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
